A detailed history of Nbc Securities, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Nbc Securities, Inc. holds 2 shares of BPMC stock, worth $223. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2
Previous 2,725 99.93%
Holding current value
$223
Previous $252,000 6.75%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

SELL
$82.48 - $101.39 $224,593 - $276,084
-2,723 Reduced 99.93%
2 $235,000
Q3 2024

Oct 15, 2024

BUY
$84.1 - $120.5 $202,176 - $289,682
2,404 Added 748.91%
2,725 $252,000
Q2 2024

Jul 10, 2024

BUY
$85.18 - $108.78 $3,492 - $4,459
41 Added 14.64%
321 $34,000
Q4 2023

Feb 07, 2024

SELL
$43.96 - $92.84 $2,241 - $4,734
-51 Reduced 15.41%
280 $25,000
Q3 2023

Nov 03, 2023

BUY
$46.9 - $66.0 $15,523 - $21,846
331 New
331 $16,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.69B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.